HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Levomilnacipran Hydrochloride

HCID 6917778
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
175131-60-9
Standard SMILES
CCN(CC)C(=O)[C@@]1(c2ccccc2)C[C@H]1CN.Cl
InChIKey
XNCDYJFPRPDERF-NQQJLSKUSA-N
Molecular formula
C15H23ClN2O
Average molar mass
282.81 g/mol
Monoisotopic mass
282.1498911

Overview

See also: Levomilnacipran (has active moiety); Milnacipran Hydrochloride (annotation moved to).

Names & identifiers

Preferred name
Levomilnacipran Hydrochloride
IUPAC
cis-(1S,2R)-2-(aminomethyl)-N,N-diethyl-1-phenylcyclopropane-1-carboxamide;hydrochloride
English name
(1S-cis)-Milnacipran Hydrochloride
Molecular formula
C15H22N2O.ClH
Molecular weight
282.81

Names & synonyms

175131-60-9LEVOMILNACIPRAN HYDROCHLORIDEF 2695 hydrochlorideF2695 HYDROCHLORIDE371U2ZK31U(1S,2R)-Milnacipran HydrochlorideF-2695 HYDROCHLORIDEDTXSID801026201RefChem:56889DTXCID201510454Fetzima(1S-cis)-Milnacipran Hydrochloride
Show more names
L-Milnacipran HClLevominaprineMilnacipran (1S-cis)D5-L-Milnacipran HClSitafloxacin Impurity 70Levomilnacipran HCl (F2695Milnacipran ((1S-cis) HCl)L-Milnacipran Hydrochloride
Levomilnacipran HClMilnacipran ((1S-cis) hydrochloride)Milnacipran (1S-cis) hydrochlorideLevomilnacipran hydrochloride [USAN]UNII-371U2ZK31UCyclopropanecarboxamide, 2-(aminomethyl)-N,N-diethyl-1-phenyl-, hydrochloride (1:1), (1S,2R)-MFCD18433402Savella

Database identifiers

CAS
175131-60-9

Properties

Computed structural propertiesFilling in

Topological polar surface area
46.3 Ų
Hydrogen bond donors
2
Hydrogen bond acceptors
2
Rotatable bonds
5
Heavy atoms
19
Formal charge
0
Complexity
295

Experimental & physicochemical properties

Human Drugs · 2 items

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Physicochemical properties

storage temp.
-20 °C · Store at -20°C
solubility
57 · DMSO:57.0(Max Conc. mg/mL);201.55(Max Conc. mM)
form
A crystalline solid
color
White to off-white
InChI
InChI=1/C15H22N2O.ClH/c1-3-17(4-2)14(18)15(10-13(15)11-16)12-8-6-5-7-9-12;/h5-9,13H,3-4,10-11,16H2,1-2H3;1H/t13-,15+;/s3
InChIKey
XNCDYJFPRPDERF-DPKVYHSMNA-N
SMILES
O=C(N(CC)CC)[C@]1(C[C@H]1CN)C1C=CC=CC=1.[H]Cl |&1:7,9,r|
FDA UNII
371 U2ZK31U · 371U2ZK31U
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
335 · H335-H319-H315

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 4 items

Danger

H301 (50%): Toxic if swallowed [Danger Acute toxicity, oral]

P261, P264, P264+P265, P270, P271, P273, P280, P301+P316, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P391, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 2 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Hazard information

Hazard Classes and CategoriesAcute Tox. 3 (50%)

Safety data

Signal word
Warning
Symbol(GHS)
GHS07
Hazard statements
H335-H319-H315
Precautionary statements
P264-P280-P305+P351+P338-P337+P313P-P264-P280-P302+P352-P321-P332+P313-P362

Chemistry & industry

Pharmacology

FDA Pharmacological Classification · 2 items

LEVOMILNACIPRAN HYDROCHLORIDE

Serotonin Uptake Inhibitors [MoA]; Serotonin and Norepinephrine Reuptake Inhibitor [EPC]; Norepinephrine Uptake Inhibitors [MoA]

MeSH Pharmacological Classification · 2 items

Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems.

Drugs that selectively block or suppress the plasma membrane transport of SEROTONIN and NORADRENALINE into axon terminals and are used as ANTIDEPRESSIVE AGENTS.

Applications · 3 items

DescriptionLevomilnacipran (Fetzima®) is a dual serotonin–norepinephrine reuptake inhibitor (SNRI) approved by the FDA in 2013 for the treatment of major depressive disorders (MDD). Levomilnacipran is the most active enantiomer of the racemate Milnacipran, which is currently used to treat pain associated with fibromyalgia. The drug was developed by Forest Laboratories and the Pierre Fabre group.

UsesThe (1S-cis)-enatiomer of Milnacipran (M344600). A selective norepinephrine and serotonin reuptake inhibitor approved for the management of fibromyalgia.

UsesThe S-enatiomer of Milnacipran (M344600).

Related reactions

0 records
New reaction record
No related reactions yet

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
PubChem CID
6917778
DTXSID
DTXSID801026201
ChEMBL
CHEMBL2105732
UNII
371U2ZK31U
EC Number
807-579-6
Precautionary statements
264 · P264-P280-P305+P351+P338-P337+P313P-P264-P280-P302+P352-P321-P332+P313-P362